The databases of these reports are partially duplicated, as shown in Table 2; however, when racial differences are not taken into account, the incidence of all grades of ILD with EGFR-TKI monotherapy is generally consistent at 1.1–2.2%. The gene discussed is EGFR; the disease is interstitial lung disease.